- Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis2016 | 1. lékařská fakulta
- Effectiveness of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with late gadolinium enhancement on cardiac magnetic resonance2020 | 2. lékařská fakulta, Ústřední knihovna
- Identification of hibernating myocardium with myocardial contrast echocardiography: comparison with late gadolinium-enhanced magnetic resonance2008 | 3. lékařská fakulta
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale2022 | 1. lékařská fakulta
- Comparison of routine contrast-enhanced computed tomography with late gadolinium enhancement cardiac magnetic resonance imaging in the detection of myocardial pathology2019 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Late morphological changes after radiosurgery of brain arteriovenous malformations: an MRI study2016 | 3. lékařská fakulta, 2. lékařská fakulta, Ústřední knihovna
- Role of magnetic resonance in the detection of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis: A single-center experience2022 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Arytmogenní kardiomyopatie levé komory2016 | 1. lékařská fakulta
- The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis2016 | 1. lékařská fakulta
- Should we fear infarct-like myocarditis?2018 | Lékařská fakulta v Plzni
- Zobrazení amyloidózy myokardu magnetickou rezonancí2019 | Lékařská fakulta v Plzni
- Komplexní přístup ke sledování pacientů po akutní myokarditidě s využitím magnetické rezonance - předběžné výsledky2014 | Lékařská fakulta v Plzni
- Orální laguinimod u pacientůs relabující-remitující roztroušenou sklerózou: 36-týdenní dvojitě slepá aktivní extenze multicentrické, dvojitě zaslepené, placebem kontrolované studie s paralelními skupinami2010 | 1. lékařská fakulta
- Imaging methods in cardiomyopathies2017 | 3. lékařská fakulta
- Hypertrophic obstructive cardiomyopathy2017 | Publikace bez příslušnosti k fakultě
- Potlačení aktivity nemoci u roztroušené sklerózy2010 | 1. lékařská fakulta
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis2012 | 2. lékařská fakulta
- Hematopoietic stem cell transplantation for multiple sclerosis2005 | 3. lékařská fakulta
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | 2. lékařská fakulta
- Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS2016 | 1. lékařská fakulta
- Alemtuzumab2014 | 1. lékařská fakulta
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | 2. lékařská fakulta
- BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis2011 | 1. lékařská fakulta
- BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis2011 | 2. lékařská fakulta
- No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a2018 | 1. lékařská fakulta
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | 1. lékařská fakulta
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | 2. lékařská fakulta
- Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy2015 | 1. lékařská fakulta
- No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study2017 | 1. lékařská fakulta
- Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management2018 | 1. lékařská fakulta